Bryan, Garnier & Co acts as Co-manager of LDR 97m$ follow-on offering on NASDAQ.

Paris, London and Austin, May 15th, 2014 – LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, closed a follow-on offering of 3,972,089 shares of its common stock at a price of $24.50.

In October 2013, Bryan, Garnier & Co acted as joint lead manager and book-runner of the company’s IPO on Nasdaq, along with Piper Jaffray and William Blair, raising 86m$ at 15$ per share. Since its IPO, the stock-price has benefitted from very positive announcements of the company, and experienced a 63% increase.

Piper Jaffray & Co. and William Blair & Company, LLC were acting as joint book-running managers for the follow-on offering. Cowen and Company, LLC andRBC Capital Markets, LLC were acting as co-lead managers. JMP Securities LLC, Stephens Inc. and Bryan, Garnier & Co. were acting as Co-managers.

About LDR Holding Corporation

LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR’s primary products are based on its exclusive VerteBRIDGE® fusion and Mobi® non-fusion technology platforms and are designed for applications in the lumbar and cervical spine. These technologies enable less invasive products, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. LDR received approval from the FDA for the Mobi-C® cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease.

 (www.ldr.com )